CEREBRAS SLIDES POST-IPO; GEMINI RISES ON $100M DEAL
AI DESK■ 1 MIN READ
FRI, MAY 15, 2026■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE
Cerebras Technologies declined following its IPO debut, while Gemini Space Station surged after the Winklevoss twins invested $100 million in the company. The investment marks a strategic pivot for Gemini away from crypto toward traditional markets.
Gemini Space Station (GEMI) shares jumped significantly after Tyler and Cameron Winklevoss announced their $100 million "strategic investment" in the company. CEO Tyler Winklevoss stated the capital will enable Gemini to transition from a cryptocurrency-focused business into a broader markets platform.
Cerebras Technologies, the AI chip maker, saw stock momentum fade after its IPO day completion. The company, which designs specialized processors for artificial intelligence workloads, faced typical post-listing volatility as initial trading enthusiasm cooled.
Magnum Ice Cream (MICC) shares jumped as much as 22%—marking the stock's largest single-day gain since its December listing—following reports that major private equity firms are evaluating acquisition interest in the consumer brand.
The moves reflect broader market dynamics: established AI infrastructure plays consolidating after debut enthusiasm, and alternative investment vehicles seeking growth acceleration through institutional backing.
■ MORE FROM THE STARTUPS DESK
Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.
14H AGO— AI Desk
Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.
14H AGO— AI Desk
Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.
21H AGO— AI Desk
H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.
YESTERDAY— Industry Desk